Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/09/2003EP1299365A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors
04/09/2003EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase
04/09/2003EP1299363A1 Polymorphic forms/hydrates of n- 4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride
04/09/2003EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
04/09/2003EP1299361A1 Pyrazole derivatives
04/09/2003EP1299360A2 Heterocycle carboxamides as antiviral agents
04/09/2003EP1299358A2 Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
04/09/2003EP1299357A1 Novel compounds
04/09/2003EP1299356A1 Novel compounds
04/09/2003EP1299355A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
04/09/2003EP1299354A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
04/09/2003EP1299352A2 Compounds to treat alzheimer's disease
04/09/2003EP1299351A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
04/09/2003EP1299350A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
04/09/2003EP1299349A2 Compounds to treat alzheimer's disease
04/09/2003EP1299348A1 Compounds and compositions for delivering active agents
04/09/2003EP1299337A1 Hydroxyphenstatin and the prodrugs thereof
04/09/2003EP1299287A1 Methods of producing a terminally sterilized topical patch preparation
04/09/2003EP1299132A2 Limiting the presence of microorganisms using polymer-bound metal-containing compositions
04/09/2003EP1299125A1 Production, stabilisation and use of reduced forms of pharmaceutical compounds
04/09/2003EP1299123A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
04/09/2003EP1299122A2 Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
04/09/2003EP1299121A2 Thromboxane receptor antagonist containing formulations for potentiating organic nitrates having vasodilating activity
04/09/2003EP1299120A2 Compositions comprising a serotonin transporter inhibitor and a 5-ht1d antagonist
04/09/2003EP1299119A2 Immunosuppressive compositions comprising an immunophilin-binding compound and a ginkgolide compound
04/09/2003EP1299118A2 Production and use of derivatized homoserine lactones
04/09/2003EP1299114A1 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
04/09/2003EP1299112A2 Compositions for treating eye discomfort, containing herbals and/or nutritional supplements and/or minerals and/or vitamins
04/09/2003EP1299110A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
04/09/2003EP1299109A1 Bifunctional antibiotics
04/09/2003EP1299108A1 A parasiticidal formulation and a method of making this formulation
04/09/2003EP1299107A2 Highly concentrated stable meloxicam solutions
04/09/2003EP1299106A2 Method for treatment and prevention of mastitis
04/09/2003EP1299104A1 Tamper-resistant oral opioid agonist formulations
04/09/2003EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
04/09/2003EP1299102A2 Use of riluzole or its salts for preventing and treating adrenoleukodystrophy
04/09/2003EP1299101A1 Carvedilol
04/09/2003EP1299100A1 Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
04/09/2003EP1299099A2 Novel use of (r)-(-)-2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
04/09/2003EP1299098A2 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel
04/09/2003EP1299097A1 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol
04/09/2003EP1299096A1 Prostaglandin compounds for treating congestive heart failure
04/09/2003EP1299095A1 Clear aqueous anaesthetic composition
04/09/2003EP1299094A2 Selective androgen receptor modulators and methods for their identification, design and use
04/09/2003EP1299093A2 Combinations of bisphosphonates, estrogenic agents and optionally estrogens
04/09/2003EP1299092A2 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel
04/09/2003EP1299091A2 Matrix controlled transdermal system for stabile derivatives of ace inhibitors
04/09/2003EP1299090A1 Oral pharmaceutical composition with controlled release and prolonged absorption
04/09/2003EP1299089A2 Drug delivery system for poorly water soluble drugs
04/09/2003EP1299088A1 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient
04/09/2003EP1299086A1 Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
04/09/2003EP1299085A2 Improved liposomal camptothecins and uses thereof
04/09/2003EP1299084A2 Liposomal antineoplastic drugs and uses thereof
04/09/2003EP1299081A1 Use of oligosaccharides to stimulate beta-endorphin production
04/09/2003EP1299068A1 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
04/09/2003EP1299059A1 Method and manufacture of a wound dressing for covering an open wound
04/09/2003EP1299048A1 Biodegradable vehicles and delivery systems of biologically active substances
04/09/2003EP1299032A1 DNA encoding human serine protease D-G
04/09/2003EP1299011A2 Composition for the treatment of migraine
04/09/2003EP1299010A1 Vitamin k and essential fatty acids
04/09/2003EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors
04/09/2003EP1198453B1 N-(indolcarbonyl-)piperazin derivatives
04/09/2003EP1149101B1 4-OXO-3,5-DIHYDRO-4$i(H)-PYRIDAZINO 4,5-$i(b)]INDOLE-1-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE
04/09/2003EP1149090B1 Novel crystalline form of the potassium salt of (s)-omeprazole
04/09/2003EP1140885B1 Method for high yield extraction of paclitaxel from paclitaxel-containing material
04/09/2003EP1140117B1 Aciclovir compositions containing dimethicone
04/09/2003EP1140055B1 Use of a 5ht 2a? and 5ht 2a/c? receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways
04/09/2003EP1133473B1 New manufacturing process
04/09/2003EP1091950B1 Substituted benzopyran derivatives and their use as anticonvulsants
04/09/2003EP1082122A4 Isoflavonoids for treatment and prevention of migraine headaches
04/09/2003EP1082116B1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
04/09/2003EP1075191B1 Phytosterol compositions
04/09/2003EP1052991B1 Topical use of loperamide for the treatment of microbial infections
04/09/2003EP1049374B1 Tuberculocidal disinfectant
04/09/2003EP1045856B1 Novel aromatic amides, preparation method and application as medicines
04/09/2003EP1023301B1 A heterocyclic chemical compound
04/09/2003EP1017681B1 Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates
04/09/2003EP1007519B1 Compounds for use in the treatment of cancer
04/09/2003EP1003568B1 Hemostatic tissue sealants
04/09/2003EP1003477B1 Therapeutical system for transdermal delivery of levonorgestrel
04/09/2003EP1001766B1 Compounds for the treatment of ccr5-mediated diseases
04/09/2003EP0996612B1 Aliphatic propargylamines as cellular rescue agents
04/09/2003EP0994701B1 Block copolymer
04/09/2003EP0993458B1 3-benzylpiperidine
04/09/2003EP0993301B1 Cocaine receptor binding ligands
04/09/2003EP0986580B1 Oligosaccharide mixtures having antithrombotic activity
04/09/2003EP0973531B1 Facilitation of wound healing with cm101/gbs toxin
04/09/2003EP0966289B1 Budesonide for the treatment of cholestatic liver diseases
04/09/2003EP0963197A4 Guanylhydrazones useful for treating diseases associated with t cell activation
04/09/2003EP0956013B1 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
04/09/2003EP0951288B1 Reactive oxygen intermediates containing compounds effective in inducing cell differentiation of malignant cells such as leukemia
04/09/2003EP0948320B1 PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF THE HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN
04/09/2003EP0946547B1 A novel compound form
04/09/2003EP0946528B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
04/09/2003EP0946165B1 Integrin antagonists
04/09/2003EP0938302B1 Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
04/09/2003EP0934280B1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives
04/09/2003EP0928200B1 Therapeutic combinations of rar antagonists and rxr agonists
04/09/2003EP0920300B1 Vegetable oil compositions
04/09/2003EP0918746B1 Immunotherapeutic agents and their use in the reduction of cytokine levels
1 ... 5508 5509 5510 5511 5512 5513 5514 5515 5516 5517 5518 5519 5520 5521 5522 5523 5524 5525 5526 5527 5528 ... 7860